Daniil Gataulin
Stock Analyst at Chardan Capital
(4.68)
# 162
Out of 5,090 analysts
121
Total ratings
58.41%
Success rate
32.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QURE uniQure | Maintains: Buy | $53 | $21.33 | +148.48% | 11 | Dec 4, 2025 | |
| RGNX REGENXBIO | Maintains: Buy | $52 | $13.18 | +294.54% | 14 | Nov 20, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $19.93 | +206.07% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $24.32 | -42.43% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $3.75 | +167.02% | 3 | Nov 14, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.65 | +304.62% | 7 | Nov 14, 2025 | |
| IRD Opus Genetics | Maintains: Buy | $9 | $2.27 | +296.48% | 3 | Nov 13, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $51 | $21.68 | +135.24% | 9 | Nov 11, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $12.59 | +66.80% | 3 | Nov 5, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.22 | +473.77% | 14 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $2.05 | +46.34% | 10 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $4.25 | +676.47% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $8.70 | +72.41% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.73 | +131.21% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $17.74 | +52.20% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.83 | +26,399.64% | 1 | Mar 7, 2024 |
uniQure
Dec 4, 2025
Maintains: Buy
Price Target: $53
Current: $21.33
Upside: +148.48%
REGENXBIO
Nov 20, 2025
Maintains: Buy
Price Target: $52
Current: $13.18
Upside: +294.54%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $19.93
Upside: +206.07%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $24.32
Upside: -42.43%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $3.75
Upside: +167.02%
MeiraGTx Holdings
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $8.65
Upside: +304.62%
Opus Genetics
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $2.27
Upside: +296.48%
Oculis Holding AG
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $21.68
Upside: +135.24%
Ocular Therapeutix
Nov 5, 2025
Maintains: Buy
Price Target: $21
Current: $12.59
Upside: +66.80%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.22
Upside: +473.77%
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $2.05
Upside: +46.34%
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $4.25
Upside: +676.47%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.70
Upside: +72.41%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.73
Upside: +131.21%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $17.74
Upside: +52.20%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.83
Upside: +26,399.64%